Glycaemic control by monoamine oxidase inhibition in a patient with type 1 diabetes

Autor:	Hamlin W. Emory, Neptune Mizrahi
Rok vydání:	2016
Předmět:	Blood Glucose Male medicine.medical_specialty Monoamine Oxidase Inhibitors Monoamine oxidase medicine.drug_class Endocrinology Diabetes and Metabolism medicine.medical_treatment Insulins Insulin Glargine 030209 endocrinology & metabolism Young Adult 03 medical and health sciences 0302 clinical medicine Neuroimaging Predictive Value of Tests Internal medicine Diabetes mellitus Internal Medicine medicine Humans Hypoglycemic Agents Circadian rhythm Brain Mapping Type 1 diabetes Monoamine oxidase inhibitor Insulin Lispro business.industry Insulin Brain Electroencephalography medicine.disease Quantitative electroencephalography Brain Waves Diabetes Mellitus Type 1 Treatment Outcome Endocrinology Drug Therapy Combination Insulin Resistance Tranylcypromine Cardiology and Cardiovascular Medicine business Biomarkers 030217 neurology & neurosurgery
Zdroj:	Diabetes and Vascular Disease Research. 14:163-165
ISSN:	1752-8984 1479-1641
DOI:	10.1177/1479164116675492
Popis:	We present clinical, electroencephalographic and low-resolution electromagnetic tomography data that support combined treatment with insulin and a monoamine oxidase inhibitor in a patient with type 1 diabetes. We suggest that brain imaging data can identify a subgroup of patients who are likely to benefit from an insulin regimen and monoamine oxidase inhibition to improve glycaemic control, cardiovascular function, normalize the circadian rhythm and restore perception of glycaemic awareness.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddb01d1643af43f01cb1b74e4427417a https://doi.org/10.1177/1479164116675492 Zobrazit plný text záznamu